Skip to main content
OpenTrials

Clinical trial condition

Malignant Neoplasm

Explore clinical trials studying Malignant Neoplasm. Study availability and eligibility vary by location and protocol.

166 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Malignant Neoplasm trial results

Completed

Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer

NCT03857620

Conditions
Carcinoma, Health Care Provider, Malignant Neoplasm, +4 more
Locations
  • Helen F Graham Cancer Center Newark, Delaware, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Memorial Health University Medical Center Savannah, Georgia, United States
View all 44 locations
View Trial Details
Completed

A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

NCT06894771

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +45 more
Locations
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301) Hackensack, New Jersey, United States
  • NEXT Oncology ( Site 0300) San Antonio, Texas, United States
  • Princess Margaret Cancer Center ( Site 0101) Toronto, Ontario, Canada
  • Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0102) Québec, Quebec, Canada
View Trial Details
Completed

Short-term Psychodynamic Psychotherapy in Serious Physical Illness

NCT05520281

Conditions
Carcinoma, Malignant Neoplasm, Mental Disorders, +5 more
Locations
  • Clinical Institute for Psychosomatic Medicine and Psychotherapy, University Medical Center Düsseldorf Düsseldorf, Germany
  • University Medical Center Hamburg Eppendorf, Department of Medical Psychology Hamburg, Germany
  • Institute of Social Work, University of Kassel Kassel, Germany
  • Psychosomatics, Psychotherapy and Psychooncology, Medicine II, University of Würzburg Würzburg, Germany
View Trial Details
Completed

A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors

NCT05082610

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • The City of Hope National Medical Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Smilow Cancer Hospital - Yale New Heaven Health New Haven, Connecticut, United States
View Trial Details

Related conditions